3 July 2026
Marston's PLC (the "Company")
LEI: 213800Q6RP3ZJ2CZR962
Notification of interests of Directors and Persons Discharging Managerial Responsibilities (PDMRs)
On 2 July 2026, the Company granted options over ordinary shares to the following Director/PDMR under the Company's Sharesave Scheme. The savings contract will commence on 1 September 2026, and the exercise price is £0.37 per ordinary share. Options granted under the Scheme are expected to be satisfied using Treasury shares.
Name Stephen Hopson | Status Director and PDMR | Number of shares under option 49,189 | Date on which exercisable 1 September 2029 |
The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.
For further information, please contact:
Bethan Raybould
General Counsel & Company Secretary
01902 907250
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | a) Name Stephen Hopson | 2. Reason for the notification | a) Position/status Director and PDMR (Chief Financial Officer) | b) Initial notification/ amendment Initial Notification | 3. Details of the Issuer | a) Name Marston's PLC | b) LEI code 213800Q6RP3ZJ2CZR962 | 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) Description of the financial instrument Identification code Ordinary Shares of 7.375 pence each ISIN: GB00B1JQDM80 | b) Nature of the transaction Grant of SAYE/Sharesave option under the Sharesave Scheme | c) Price(s) and volume(s)
| d) Aggregated information - Aggregate volume - Price N/A | e) Date of the transaction 2026-07-02 | f) Place of the transaction Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHEAXXDELAKEEA